Endologix (NSDQ:ELGX) yesterday spiked its plan to sell as much as $25 million worth of its own stock, saying it has no intention of selling stock over the short term. The Irvine, Calif.-based company had tapped Piper Jaffray to offer more than 22.2 million shares at $6.45 apiece, with the proceeds earmarked for manufacturing, clinical trials, […]
Stealthy Provisio Medical adds $2m
Stealthy endovascular device developer Provisio Medical added more than $2 million to its coffers in a new equity round, according to a regulatory filing. San Diego-based Provisio is tight-mouthed about its technology, apart from revealing its focus on endovascular therapy on its single-page website. The equity and preferred stock offering brought in $2.3 million of a […]
Essex Woodlands raises $745m for second fund
Private equity shop Essex Woodland yesterday said it raised $745 million for its over-subscribed second EW Healthcare Partners fund. The raise is nearly $100 million more than EW’s $650 million goal and tops its first fund b y some $200 million, the New York City-based firm said. The PE investor said it looks for fast-growing, […]
Ambu dives on spiked distributor deal, lowered outlook
Shares in Danish endoscope maker Ambu (CPH:AMBU-B) took a dive today in Copenhagen after it spiked its deal with a U.S. distributor and slashed its outlook on the rest of the year. The Ballerup, Denmark-based company said it’s planning to cut ties with Tri-anim Health Services on the U.S. sales of its aScope pulmonary endoscopes […]
Edwards Lifesciences slides after FDA slaps Class I on Sapien 3 Ultra recall
Edwards Lifesciences (NYSE:EW) shares slid today after the FDA slapped Class I status on last month’s recall of its Sapien 3 Ultra replacement heart valve. Irvine, Calif.-based Edwards in July warned doctors about the risk of burst balloons during implantation of the transcatheter aortic valve replacement, cautioning physicians to closely follow the instructions for use to […]
Varian closes $90m microspheres buy from Boston Scientific
Hot on the heels of the $4 billion buyout of BTG by Boston Scientific (NYSE:BSX), Varian (NYSE:VAR) said yesterday that it closed the $90 million acquisition of Boston’s microspheres business. The deal for the drug-eluting and “bland” embolic microsphere business, which includes the Oncozene, Embozene and Embozone Tandem products, was struck to mollify anti-trust regulators about the BTG […]
Avinger prices $5m offering
Avinger (NSDQ:AVGR) yesterday priced a stock offering worth nearly $5 million for its line of devices to treat peripheral artery disease. The $4.5 million offering, of more than 3.8 million shares at $1.18 apiece, also includes a 45-day underwriters option on another 572,000 shares that would add $675,000 if exercised in full. The float is slated […]
Report: Philips fired whistleblower who warned of graft
Royal Philips (NYSE:PHG) reportedly fired a whistleblower in 2011 after he warned about suspicious sales of medical equipment to the Brazilian government. Brazilian prosecutors claimed the Amsterdam-based company, among others, was part of an international health-care cartel last year. Jose Israel Masiero Filho informed Philips of his suspicions of illegal activity as far back as 2010, […]
Alcon slides on Q2 earnings miss
Alcon (NYSE:ALC) shares took a hit today after the former Novartis (NYSE:NVS) vision care business posted second-quarter earnings that missed the consensus forecast, despite a healthy top-line beat. Geneva-based Alcon, which Novartis spun into a public company in April, reported a swing to Q2 red with losses of -$390.0 million, or -80¢ per share, on sales growth […]
Delcath Systems raises another $9.5m
Delcath Systems (OTC:DCTH) has closed on a $9.5 million private placement round, bringing the total amount raised since July to $29.5 million. The Queensbury, N.Y.-based company priced the round at $1,000 per unit, with each unit consisting of a preferred convertible share worth 16,667 common shares, at a 6¢ strike price, and a five-year warrant for […]
Judge approves $160k settlement between ex-Sientra CEO Zeini, SEC
A California federal judge last week approved a settlement between former Sientra (NSDQ:SIEN) CEO Hani Zeini and the U.S. Securities & Exchange Commission, ordering him to pay a $160,000 fine and barring him from working at publicly traded companies for five years for his alleged scheme to hide a problem at the company that led to […]
- 1
- 2
- 3
- …
- 538
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube